Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
Skip to main content

Advertisement

Springer Nature Link
Log in

The role of NMDA receptors in the slow neuronal degeneration of Parkinson's disease

  • Review Article
  • Published:
Amino Acids Aims and scope Submit manuscript

Summary

Parkinson's disease is a disorder, in which neurons of various neuronal systems degenerate. Furthermore, in such degenerating neurons, the cytoskeleton seems to be affected. In this respect, Parkinson's disease resembles Alzheimer's disease. Since it has been shown, that elevated levels of intracellular calcium can disrupt the cytoskeleton and that the stimulation of glutamate (NMDA) receptors can cause high intracellular concentrations of calcium, it has been suggested, that the stimulation of glutamate receptors plays a role in the slow degeneration in Alzheimer's and Parkinson's disease. In case of the degeneration of the dopaminergic nigrostriatal system in Parkinson's disease, neurons that contain calcium binding protein appear to be less vulnerable than the neurons that lack it, suggesting that calcium binding protein might protect these neurons from degeneration by preventing that cytosolic calcium concentrations increase excessively. And, since there is in the nigrostriatal system a glutamatergic afferent pathway (the prefrontonigral projection) and since dopaminergic nigrostriatal neurons contain postsynaptic NMDA receptors, glutamatergic excitation may play a role in the degeneration of the nigrostriatal system in Parkinson's disease. If so, it may be possible to protect the neurodegeneration of these dopaminergic neurons by NMDA receptor antagonists.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Agid Y (1991) Parkinson's disease: pathophysiology. Lancet 337: 1321–1324

    Google Scholar 

  • Albin RL, Makowiec RL, Holingsworth ZR, Dure IVLS, Penney JB, Young AB (1992) Excitatory amino acid binding sites in the basal ganglia of the rat: a quantitative autoradiographic study. Neurosci 46: 35–48

    Google Scholar 

  • Anglade P, Vyas S, Javoy-Agid F, Herrera MT, Michel PP, Marquez J, Mouatt-Prigent A, Ruberg M, Hirsch EC, Agid Y (1997) Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol Pathol 12: 25–31

    Google Scholar 

  • Beal MF (1992) Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann Neurol 31: 119–130

    Google Scholar 

  • Bethlem J, Den Hartog Jager WA (1960) The incidence and charateristics of Lewy bodies in idiopathic paralysis agitans (Parkinson's disease). J Neurol Neurosurg Psychiatry 23: 74–80

    Google Scholar 

  • Bevan MD, Bolam JP, Crossman AR (1994) Convergent synaptic input from the neostriatum and the subthalamus onto identified nigrothalamic neurons in the rat. Eur J Neurosci 6: 320–334

    Google Scholar 

  • Braak E, Braak H, Mandelkow EM (1994a) A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 87: 554–567

    Google Scholar 

  • Braak H, Braak E, Yilmazer D, de Vos RAI, Jansen ENH, Bohl J, Jellinger K (1994b) Amygdala pathology in Parkinson's disease. Acta Neuropathol 88: 493–500

    Google Scholar 

  • Braak H, Braak E, Yilmazer D, de Vos RAI, Jansen ENH, Bohl J (1996) Pattern of brain destruction in Parkinson's and Alzheimer's diseases. J Neural Transm 103: 455–490

    Google Scholar 

  • Choi DW (1992) Excitotoxic cell death. Neurobiology 23: 1261–1276

    Google Scholar 

  • Christoffersen CL, Meltzer CT (1995) Evidence for N-methyl-D-aspartate and AMPA subtypes of the glutamate receptor on substantia nigra dopamine neurons: possible preferential role for N-methyl-D-aspartate receptors. Neurosci 67: 373–381

    Google Scholar 

  • Galloway PG, Grundke-Igbal I, Iqbal K, Perry G (1988) Lewy bodies contain epitopes both shared and distinct from Alzheimer neurofibrillary tangles. J Neuropathol Exp Neurol 47: 654–663

    Google Scholar 

  • Gerfen CR, Herkenham M, Thibault J (1987a) The neostriatal mosaic: II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems. J Neurosci 7:3915–3934

    Google Scholar 

  • Gerfen CR, Baimbridge KG, Thibault J (1987b) The neostriatal mosaic: III. Biochemical and developmental dissociation of patch-matrix mesostriatal systems. J Neurosci 7: 3935–3944

    Google Scholar 

  • German AM, McGowan A, O'Neill C, Cotter T (1996) Oxidative stress and apoptosis in neurodegeneration. J Neurol Sci 139 [Suppl]: 45–52

    Google Scholar 

  • Gibb WRG (1988) The neuropathology of Parkinsonian disorders. In: Jankovic J, Toloa E (eds) Parkinson's disease and movement disorders. Urban and Schwarzenberg, Baltimore Munich, pp 205–223

    Google Scholar 

  • Gibb WRG, Lees AJ (1991) Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. J Neurol Neurosurg Psychiatry 54: 388–396

    Google Scholar 

  • Goedert M (1993) Tau protein and the neurofibrillary pathology of Alzheimer's disease. Trends Neurosci 16: 460–465

    Google Scholar 

  • Goldman JE, Yen S-H, Chin F-C, Peress NS (1983) Lewy bodies of Parkinson's disease contain neurofilament antigens. Science 221: 1082–1084

    Google Scholar 

  • Greene JG, Greenamyre JT (1995a) Characterization of the excitotoxic potential of the reversible succincte dehydrogenase inhibitor malonate. J Neurochem 64: 430–436

    Google Scholar 

  • Greene JG, Greenamyre JT (1995b) Exacerbation of NMDA, AMPA and L-glutamate excitotoxicity by the succincte dehydrogenase inhibitor malonate. J Neurochem 64: 2332–2338

    Google Scholar 

  • Hammond C, Deniau JM, Rizk A, Feyer J (1978) Electrophysiological demonstration of an excitatory subthalamonigral pathway in the rat. Brain Res 151: 235–244

    Google Scholar 

  • Hof PR, Morrison JH (1995) Neurofilament protein defines regional patterns of cortical organization in the Macaque monkey visual system: a quantitative immunohistochemical analysis. J Comp Neurol 352: 161–186

    Google Scholar 

  • Hunter S (1985) The rostral mesencephalon in Parkinson's disease and Alzheimer's disease. Acta Neuropathol 68: 53–58

    Google Scholar 

  • Huntley GW, Vicker JC, Morrison JH (1994) Cellular and synaptic localization of NMDA and non-NMDA receptor subunits in neocortex: organizational features related to cortical circuitry, function and disease. Trends Neurosci 17: 536–543

    Google Scholar 

  • Iqbal K, Alonso AC, Gong CX, Khatoon S, Singh TJ, Grundke-Igbal I (1994) Mechanism of neurofibrillary degeneration in Alzheimer's disease. Mol Neurobiol 9: 119–123

    Google Scholar 

  • Kornhuber J, Kim J-S, Kornhuber M, Kornhuber HH (1984) The corticonigral projection: reduced glutamate content in the substantia nigra following frontal cortex ablation in the rat. Brain Res 322: 124–126

    Google Scholar 

  • Kornhuber J, Weller M, Schoppenmeyer K, Riederer P (1994) Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties. J Neural Transm [Suppl] 43: 91–104

    Google Scholar 

  • Lasek RJ, Oblinger MM, Drake PF (1983) The molecular biology of neuronal geometry: the expression of neurofilament genes influences axonal diameter. Cold Spring Harbor Symp Quant Biol 48: 731–744

    Google Scholar 

  • Le W-D, Colom LV, Wie W, Smith G, Alexianu M, Appel SH (1995) Cell death induced byβ-amyloid 1-40 in MES 23.5 hybrid clone: the role of nitric oxide and NMDA-gated channel activation leading to apoptosis. Brain Res 686: 49–60

    Google Scholar 

  • Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel RE (1992) Beta-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicitity. J Neurosci 12: 376–389

    Google Scholar 

  • Mercuri NB, Stratta F, Calabres P, Bernard G (1992) A voltage-clamp analysis of NMDAinduced responses on dopaminergic neurons of the rat substantia nigra zona compacta and ventral tegmental area. Brain Res 593: 51–56

    Google Scholar 

  • Mitchell IJ, Lawson S, Moser B, Laidlaw SM, Cooper AJ, Walkinsaw G, Waters CM (1994) Glutamate-induced apoptosis results in a loss of striatal neurons in the Parkinsonian rat. Neurosci 63: 1–5

    Google Scholar 

  • Naito A, Kita H (1994) The cortico-nigral projection in the rat: an anterograde tracing study with biotynilated dextran amine. Brain Res 637: 17–32

    Google Scholar 

  • Nauta HJW, Cole M (1978) Efferent projections of the subthalamic nucleus: an autoradiographic study in monkey and cat. J Comp Neurol 180: 1–16

    Google Scholar 

  • Qualman SJ, Haupt HM, Young P, Hamilton SR (1984) Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's disease. Gastroentrology 87: 848–856

    Google Scholar 

  • Sonsalla PK, Nicklas WJ, Heikkila RE (1989) Role of excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. Science 243: 398–400

    Google Scholar 

  • Sonsalla PK, Zeevalk GD, Manzino L, Giovanni A, Nicklas WJ (1992) MK-801 fails to protect against the dopaminergic neuropathology produced by systemic 1-methyl-4phenyl-1,2,3,6-tetrahydropyridine in mice or intranigral 1-methyl-4-phenylpyridinium in rats. J Neurochem 58: 1979–1982

    Google Scholar 

  • Standaert DG, Testa CM, Young AB, Penney JB Jr (1994) Organization of N-methyl-Daspartate glutamate receptor gene expression in the basal ganglia of the rat. J Comp Neurol 343: 1–16

    Google Scholar 

  • Turski L, Bressler K, Rettig K-J, Löschmann P-A, Wachtel H (1991) Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists. Nature 349: 414–418

    Google Scholar 

  • Youdim MBH, Ben-Sacher D, Riederer P (1994) The enigma of neuromelanin in Parkinson's disease substantia nigra. J Neural Transm [Suppl] 43: 113–122

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neuropharmacology, Med. Naturw. Forschungszentrum, Universität of Tübingen, Ob dem Himmelriech, D-72074, Tübingen, Germany

    L. D. Loopuijt & W. J. Schmidt

Authors
  1. L. D. Loopuijt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. J. Schmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Loopuijt, L.D., Schmidt, W.J. The role of NMDA receptors in the slow neuronal degeneration of Parkinson's disease. Amino Acids 14, 17–23 (1998). https://doi.org/10.1007/BF01345237

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01345237

Keywords

Search

Navigation